Regeneron's Eylea HD injection 8 mg approved by FDA for the treatment of macular edema following RVO | Optometry Times - Clinical News

Published on November 21, 2025
Additionally, the FDA approved a monthly dosing option for some patients who may benefit from resuming this dosing schedule across approved indications.
Continue reading on website
Other news

Adult Amblyopia and Strabismus Associated With Higher-Order Processing Deficits

November 21, 2025
Adults with amblyopia or strabismus may experience lingering cognitive and functional challenges that extend beyond reduced visual acuity. Photo: Christopher L. Suhr, OD. Click image to enlarge. A new study demonstrates that adults with amblyopia and/or strabismus face significant challenges in higher-order visual processing and executive function. These visuo-cognitiv

VSP Vision and the American Optometric Association collaborate on doctor contracting commitment | Optometry Times - Clinical News

November 21, 2025
To help doctors better evaluate amendments to existing plan agreements, changes will be summarized in a cover letter and clearly display all changes over the previous amendment for simple comparison.